How unfortunate if taxes restrain the global cooperation so essential to progress, including life-saving cures.

Akums Drugs and Pharmaceuticals Ltd., India's leading CDMO, reported a 12.4% YoY revenue growth in Q4 FY25 with a focus on ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

Teva Pharmaceutical Industries Ltd. today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies Global Healthcare ...

Danish privately-held drugmaker MC2 Therapeutics today announced the appointment of Trine Ahlgreen as chief executive (CEO).

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

Harshad Borawake from Mirae Asset advises investors to maintain diversified asset allocation amid market volatility. He ...

Dr. Bika holds a Ph.D. in Materials Science and Engineering from the University of Pennsylvania, a Master of Science in ...

With an R&D spend, up 16% from FY24, Akums continues to deepen its innovation capabilities, develop complex formulations, and enrich its portfolio. The company's emphasis on quality-focused ...

CHENNAI: Asia’s leading healthcare-focused private equity firm today announced the final close of its Fund III, securing ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and Argentine Minister of Health Mario Lugones slammed the ...

GRIN Therapeutics, Inc., a leader in the development of therapies to treat serious neurodevelopmental disorders, and Angelini Pharma, part of the privately owned Angelini Industries, today announced a ...